Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Safer glucocorticoids for inflammatory/allergic disorders

Sep. 22, 1997

Glaxo Wellcome develops glucocorticoids with favorable side effect profile

Sep. 19, 1997

Transdermal lidocaine patch enters phase II/III for allergic rhinitis

Sep. 17, 1997

First U.S. clinical trial of pranlukast

Sep. 17, 1997

Takeda reports MIP-1alpha/RANTES receptor antagonists

Sep. 11, 1997

Bayer discloses inhibitors of leukotriene synthesis

Sep. 10, 1997

Inflazyme contracts Inveresk Research for IND support

Sep. 9, 1997

Celltech prepares improved PDE IV inhibitors

Sep. 8, 1997

Licensing agreement signed for OxSODrol

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...